Syntellix AG was founded in 2008 in Hanover under the leadership of Prof. Dr. Utz Claassen. The startup develops magnesium-based implants that are inserted after bone fractures and dissolve in the body. With the help of a network of outstanding scientists, the company succeeded in developing a material (MAGNEZIX®) that, despite its high stability, is completely absorbed by the body and replaced by bone tissue. CEO Claassen explains how the implants work and why Syntellix products can reduce surgical risks.
You have not agreed to view this article. By clicking on 'Show content', you agree that we may display this content. This allows personal data to be transmitted to third-party platforms.